4//SEC Filing
CATABASIS PHARMACEUTICALS INC 4
Accession 0001104659-16-097471
$ATXSCIK 0001454789operating
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:18 PM ET
Size
5.5 KB
Accession
0001104659-16-097471
Insider Transaction Report
Form 4
Cunnane Deirdre A.
SVP, General Counsel
Transactions
- Award
Stock Option (right to buy)
2016-02-11+23,000→ 23,000 totalExercise: $4.57Exp: 2026-02-10→ Common Stock (23,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 11, 2016 and is scheduled to vest over four years, with 25% of the shares vesting on the first anniversary of February 11, 2016 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
Documents
Issuer
CATABASIS PHARMACEUTICALS INC
CIK 0001454789
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001454789
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 6:18 PM ET
- Size
- 5.5 KB